We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
Cap. Flow
+$1.03B
Cap. Flow %
14.89%
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$73.4M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$72M
3
JNJ icon
Johnson & Johnson
JNJ
+$64.2M
4
CL icon
Colgate-Palmolive
CL
+$62.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$52.1M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$73.1M
2
FRPT icon
Freshpet
FRPT
+$58.3M
3
PARA
Paramount Global Class B
PARA
+$48M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$43.7M
5
KYNB
Kyntra Bio
KYNB
+$32.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Consumer Staples 5.26%
3 Consumer Discretionary 4.88%
4 Technology 4.62%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$63.3M 0.91%
4,100,000
-1,072,000
-21% -$17.9M
MSFT icon
27
Microsoft
MSFT
$3.66T
$58.4M 0.84%
202,676
-21,324
-10% -$5.44M
SWAV
28
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$55.5M 0.8%
256,000
+204,000
+392% +$39.7M
MDT icon
29
Medtronic
MDT
$110B
$54.7M 0.79%
678,000
+6,000
+0.9% +$489K
CENTA icon
30
Central Garden & Pet Co Class A
CENTA
$2.42B
$53.3M 0.77%
1,705,000
-181,250
-10% -$5.57M
ISRG icon
31
Intuitive Surgical
ISRG
$130B
$53.1M 0.77%
208,000
+8,000
+4% +$1.97M
NVO
32
Novo Nordisk
NVO
$196B
$46.5M 0.67%
584,000
-40,000
-6% -$2.84M
PARA
33
DELISTED
Paramount Global Class B
PARA
$46M 0.66%
2,064,000
-2,236,000
-52% -$48M
AUPH icon
34
Aurinia Pharmaceuticals
AUPH
$1.92B
$45.7M 0.66%
4,172,000
-828,000
-17% -$7.29M
POST icon
35
Post Holdings
POST
$4.11B
$45.7M 0.66%
508,410
+191,410
+60% +$17.4M
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$44.7M 0.64%
1,836,000
+44,000
+2% +$963K
KYNB
37
Kyntra Bio
KYNB
$28M
$43.1M 0.62%
92,480
-62,080
-40% -$32.8M
MGNX icon
38
MacroGenics
MGNX
$248M
$42.7M 0.62%
5,960,000
-132,000
-2% -$795K
REGN icon
39
Regeneron Pharmaceuticals
REGN
$78.3B
$42.7M 0.62%
52,000
-58,000
-53% -$43.7M
BHVN icon
40
Biohaven
BHVN
$2.07B
$42.7M 0.61%
3,124,000
+400,000
+15% +$6.37M
DICE
41
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$39.4M 0.57%
+1,376,000
New +$40.8M
CRSP icon
42
CRISPR Therapeutics
CRSP
$5.23B
$37.3M 0.54%
824,000
-212,000
-20% -$10.3M
UBER icon
43
Uber
UBER
$147B
$34.6M 0.5%
1,092,000
+468,000
+75% +$14.8M
KHC icon
44
Kraft Heinz
KHC
$31.6B
$32.9M 0.47%
850,000
+160,000
+23% +$6.34M
TOST icon
45
Toast
TOST
$19.6B
$32.3M 0.47%
1,820,370
+564,370
+45% +$11.1M
OFIX icon
46
Orthofix Medical
OFIX
$493M
$30.8M 0.44%
1,836,000
+1,036,000
+130% +$20.3M
DOCU
47
DocuSign
DOCU
$11B
$30.5M 0.44%
524,000
+108,000
+26% +$6.44M
MDGL icon
48
CALL
Madrigal Pharmaceuticals
MDGL
$11.7B
$30.3M 0.44%
+125,000
New +$34.1M
EVBG
49
DELISTED
Everbridge, Inc. Common Stock
EVBG
$29.5M 0.42%
850,000
-222,000
-21% -$7.1M
CDNA icon
50
CareDx
CDNA
$2.44B
$28.7M 0.41%
3,136,000
+2,636,000
+527% +$33.7M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.

  • Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
  • Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
  • Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
  • Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
  • Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.